A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues

被引：6
|
作者：
Min, Long [1 ,2 ]
Sun, Qiu [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2022年 / 7卷 / 01期
关键词：
D O I：
10.1038/s41392-022-00956-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase
    Khan, Suliman
    Attar, Farnoosh
    Bloukh, Samir Haj
    Sharifi, Majid
    Nabi, Faisal
    Bai, Qian
    Khan, Rizwan Hasan
    Falahati, Mojtaba
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 181 : 605 - 611
  • [22] Potential PDE4B inhibitors as promising candidates against SARS-CoV-2 infection
    Giuzio, Federica
    Bonomo, Maria Grazia
    Catalano, Alessia
    Infantino, Vittoria
    Salzano, Giovanni
    Monne, Magnus
    Geronikaki, Athina
    Petrou, Anthi
    Aquaro, Stefano
    Sinicropi, Maria Stefania
    Saturnino, Carmela
    BIOMOLECULAR CONCEPTS, 2023, 14 (01)
  • [23] CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection
    Pourani, Mohammad Reza
    Nekooghadam, Sayyed Mojtaba
    Youssefian, Leila
    Vahidnezhad, Hassan
    Abdollahimajd, Fahimeh
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [24] Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2
    Hijikata, Atsushi
    Shionyu-Mitsuyama, Clara
    Nakae, Setsu
    Shionyu, Masafumi
    Ota, Motonori
    Kanaya, Shigehiko
    Hirokawa, Takatsugu
    Nakajima, Shogo
    Watashi, Koichi
    Shirai, Tsuyoshi
    FEBS OPEN BIO, 2022, 12 (01): : 285 - 294
  • [25] A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
    Jo, Seri
    Kim, Suwon
    Yoo, Jahyun
    Kim, Mi-Sun
    Shin, Dong Hae
    MICROORGANISMS, 2021, 9 (04)
  • [26] Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
    Borbone, Nicola
    Piccialli, Gennaro
    Roviello, Giovanni Nicola
    Oliviero, Giorgia
    MOLECULES, 2021, 26 (04):
  • [27] Polymeric Materials as Potential Inhibitors Against SARS-CoV-2
    Yunusa Umar
    Sirhan Al-Batty
    Habibur Rahman
    Omar Ashwaq
    Abdulla Sarief
    Zakariya Sadique
    P. A. Sreekumar
    S. K. Manirul Haque
    Journal of Polymers and the Environment, 2022, 30 : 1244 - 1263
  • [28] Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
    Leyfman, Yan
    Gohring, Greta
    Joshi, Muskan
    Menon, Gayathri Pramil
    Van de Kieft, Alexandra
    del Rivero, Tania
    Bellio, Michael A.
    Mitrani, Maria Ines
    MOLECULAR THERAPY, 2023, 31 (05) : 1196 - 1200
  • [29] Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants
    Ferdous, Nadim
    Reza, Mahjerin Nasrin
    Islam, Md Shariful
    Emon, Md Tabassum Hossain
    Mohiuddin, A. K. M.
    Hossain, Mohammad Uzzal
    RSC ADVANCES, 2021, 11 (50) : 31460 - 31476
  • [30] Screening for inhibitors against SARS-CoV-2 and its variants
    Yuan Weijing
    Dong Xiaojing
    Chen Lan
    Lei Xiaobo
    Zhou Zhuo
    Guo Li
    Wang Jianwei
    生物安全与健康（英文）, 2022, 04 (03) : 186 - 192
12345